Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Nemaska Lithium closes prospectus supplement offering

Reading Time 1 minute read Subscribe



Confidential Clients

On April 11, 2013, Nemaska Lithium Inc. (“Nemaska”) closed the sale of 14,123,168 units (the “Units”) for gross proceeds of $4.23 million. Each Unit is comprised of one common share of Nemaska and one-half of one common share purchase warrant (the “Warrants”). Each whole Warrant is exercisable for a period of 24 months to purchase one common share of Nemaska at a price of $0.40. The dealer syndicate for the offering was co-led by Euro Pacific Canada Inc., as sole book runner, and Casimir Capital Ltd., and included Mackie Research Capital Corporation and National Bank Financial Inc. (collectively, the “Agents”). Nemaska filed with the securities commissions and other similar regulatory authorities in the provinces of Québec, Ontario, Alberta and British Columbia a prospectus supplement to the short form base shelf prospectus of Nemaska dated March 4, 2013. Under the base shelf prospectus, Nemaska may issue up to $100 million of securities from time to time over the 25 months following the date of the base shelf prospectus. The Agents were advised in this transaction by a team from Fasken Martineau led by Krisztián Tóth and Alex Nikolic and included Sophie Lessard Berger, Martin R. Gagné and Kimberley Okell.



    Receive email updates from our team